Cellular receptors for foot and mouth disease virus

Intervirology

Volumn 52, Issue 4, 2009, Pages 201-212

  Ruiz Saenz J ^a,b   Goez, Y ^c   Tabares, W ^a   Lopez Herrera A ^b  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^c Instituto Colombiano de Medicina Tropical   (Colombia)

Author keywords

Foot and mouth disease virus; Heparan sulfate (source: MESH); Integrins; Virus receptors

Indexed keywords

CD51 ANTIGEN; CHONDROITIN 4 SULFATE; DERMATAN SULFATE; HEPARAN SULFATE; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1; VIRUS RECEPTOR;

ENDOCYTOSIS; ENDOSOME; EXTRACELLULAR MATRIX; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; RNA GENE;

ANIMALS; FOOT-AND-MOUTH DISEASE VIRUS; HEPARITIN SULFATE; INTEGRINS; RECEPTORS, VIRUS; VIRUS ATTACHMENT; VIRUS INTERNALIZATION;

ANIMALIA; APHTHOVIRUS; BOS; FOOT-AND-MOUTH DISEASE VIRUS; MIRIDAE;

EID: 67649234159     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000226121     Document Type: Review

References (70)

1. Manson PW, Grubman MJ, Baxt B: Molecular basis of pathogenesis of FMDV. Virus Res 2003; 91: 9-32.
2. Domingo E, Escarmís C, Baranowski E, Ruiz-Jarabo CM, Carrillo E, Núñez JI, Sobrino F: Evolution of foot and mouth disease virus. Virus Res 2003; 91: 47-63. (Pubitemid 36078430)
3. Knowles NJ, Samuel AR: Molecular epidemiology of foot and mouth disease virus. Virus Res 2003; 91: 65-80. (Pubitemid 36078431)
4. Jackson T, King AM, Stuart D, Fry E: Structure and receptor binding. Virus Res 2003; 91: 33-46.
5. Burman A, Clark S, Abrescia NG, Fry EE, Stuart DI, Jackson T: Specificity of the VP1 GH loop of foot-and-mouth disease virus for alpha-v integrins. J Virol 2006; 80: 9798-9810. (Pubitemid 44435654)
6. Fry EE, Stuart DI, Rowlands DJ: The structure of foot-and-mouth disease virus. Curr Top Microbiol Immunol 2005; 288: 71-101.
7. Alcalá P, Feliu JX, Arís A, Villaverde A: Efficient accommodation of recombinant, foot-and-mouth disease virus RGD peptides to cell-surface integrins. Biochem Biophys Res Commun 2001; 285: 201-206. (Pubitemid 32918054)
8. Alexandersen S, Zhang Z, Donaldson AI, Garland AJ: The pathogenesis and diagnosis of foot-and-mouth disease. J Comp Pathol 2003; 129: 1-36.
9. Thomson GR, Vosloo W, Bastos AD: Foot and mouth disease in wildlife. Virus Res 2003; 91: 145-161.
10. Grubman MJ, Baxt B: Foot-and-mouth disease. Clin Microbiol Rev 2004; 17: 465-493.
11. Doel TR: FMD vaccines. Virus Res 2003; 91: 81-99.
12. OIE: World Organization for Animal Health 2006: Foot And Mouth Disease Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (Mammals, Birds and Bees), ed 5. Paris, World Organization for Animal Health, 2006, vol 1, 2, chap 2.1.1.
13. O'Donnell V, LaRocco M, Duque H, Baxt B: Analysis of foot-and-mouth disease virus internalization events in cultured cells. J Virol 2005; 79: 8506-8518. (Pubitemid 40853551)
14. Berryman S, Clark S, Monaghan P, Jackson T: Early events in integrin αvβ6 mediated cell entry of foot-and-mouth disease virus. J Virol 2005; 79: 8519-8534. (Pubitemid 40853552)
15. Monaghan P, Simpson J, Murphy C, Durand S, Quan M, Alexandersen S: Use of confocal immunofluorescence microscopy to localize viral nonstructural proteins and potential sites of replication in pigs experimentally infected with foot-and-mouth disease virus. J Virol 2005; 79: 6410-6418. (Pubitemid 40617244)
16. Springer TA: Predicted and experimental structures of integrins and β -propellers. Curr Opin Struct Biol 2002; 12: 802-813.
17. Miller LC, Blakemore W, Sheppard D, Atakilit A, King AM, Jackson T: Role of the cytoplasmic domain of the b-subunit of integrin αvβ6 in infection by foot-and-mouth disease virus. J Virol 2001; 75: 4158-11464 (Pubitemid 32410128)
18. Grundstrom G: Functional studies of collagen-binding integrins α2β1 and α11β1. Interplay between integrins and platelet-derived growth factor receptors. Acta Universitatis Upsaliensis. Comprehensive summaries of Uppsala Dissertations from Faculty of Medicine, Uppsala University, 2003, p 97.
19. Hynes RO: Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992; 69: 11-25.
20. Hynes RO: Integrins: bidirectional, allosteric signaling machines. Cell 2002; 100: 673-687.
21. Dedhar S, Hannigan GE: Integrin cytoplasmic interactions and bidirectional transmembrane signaling. Curr Opin Cell Biol 1996; 8: 657-669. (Pubitemid 26381723)
22. Montgomery AM, Reisfeld RA, Cheresh DA: Integrin αvβ3 rescues melanoma cells from apoptosis in three dimensional dermal collagen. Proc Natl Acad Sci USA 1994; 91: 8856-8860.
23. O'Toole TE, Katagiri Y, Faull RJ, Peter RK, Tamura R, Quaranta R, Loftus JC, Shattil SJ, Ginsberg MH: Integrin cytoplasmic domains mediate inside-out signal-transduction. J Cell Biol 1994; 124: 1047-1059. (Pubitemid 24109406)
24. Faull RJ, Ginsberg MH: Inside-out signaling in integrins. Education Program 26th Congr Int Soc Haematology, Singapore, 1996.
25. Hughes PE, Pfaff M: Integrin affinity modulation. Trends Cell Biol 1998; 8: 358-364.
26. Plow EF, Haas TA, Zhang L, Loftus J, Smith JW: Ligand binding to integrins. J Biol Chem 2000; 275: 21785-21788.
27. Dickenson SK, Mathis NL, Rahman M, Bergelson JM, Santoro SA: Determinants of ligand binding specificity of the alpha(1) be ta(1) and alpha(2)beta(1) integrins. J Biol Chem 1999; 274: 32182-32191.
28. Hemler ME: Integrin associated proteins. Curr Opin Cell Biol 1998; 10: 578-585.
29. Humpries MJ: Integrin structure. Biochem Soc Trans 2000; 28: 311-339.
30. Mould AP, Akiyama SK, Humphries MJ: Regulation of integrin α5β1-fibronectin interactions by divalent cations. J Biol Chem 1995; 270: 26270-26277.
31. Smith JW, Piotrowicz RS, Mathis D: A mechanism for divalent cation regulation of β 3-integrins. J Biol Chem 1994; 269: 960-967.
32. Hu DD, Hoyer JR, Smith JW: Ca21 suppresses cell adhesion to osteopontin by attenuating binding affinity for integrin αvβ3. J Biol Chem 1995; 270: 9917-9925.
33. Mateu MG, Valero ML, Andreu D, Domingo E: Systematic replacement of amino acid residues within an Arg-Gly-Asp-containing loop of foot-and-mouth disease virus and effects on cell recognition. J Biol Chem 1996; 271: 12814-12819. (Pubitemid 126545210)
34. Xiong JP, Stehle T, Zhang R, Joachimiak A, Frech M, Goodman SL, Arnaout MA: Crystal structure of the extracellular segment of integrin aVb3 in complex with an Arg-Gly-Asp ligand. Science 2002; 296: 151-155. (Pubitemid 34280076)
35. Berinstein A, Roivainen M, Hovi T, Mason PW, Baxt B: Antibodies to the vitronectin receptor (integrin αvβ3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells. J Virol 1995; 69: 2664-2666.
36. Mason PW, Reider E, Baxt B: RGD sequence of foot-and mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependant enhancement pathway. Proc Natl Acad Sci USA 1994; 91: 1932-1936.
37. Leippert M, Beck E, Weiland F, Pfaff E: Point mutations within the bG-bH loop of foot-and-mouth disease virus O1K affects attachment to target cells. J Virol 1997; 71: 1046-1051.
38. Neff S, Mason PW, Baxt B: High-efficiency utilization of the bovine integrin αvβ3 as a receptor for foot-and-mouth disease virus is dependent on the bovine β 3 subunit. J Virol 2000; 74: 7298-7306. (Pubitemid 30613075)
39. Neff S, Sa-Carvalho D, Rieder E, Mason PW, Blystone SD, Brown EJ, Baxt B: Foot-andmouth disease virus virulent for cattle utilizes the integrin αvβ3 as its receptor. J Virol 1998; 72: 3587-3594. (Pubitemid 28188655)
40. Calvete JJ, Henschen A, González-Rodríguez J: Assignment of disulphide bonds in human platelet GPIIIa: a disulphide pattern for the b-subunits of the integrin family. Biochem J 1991; 274: 63-71.
41. Green L, Mould AP, Humphries MJ: The integrin beta subunit. Int J Biochem Cell Biol 1998; 30: 179-184.
42. Jackson T, Sharma A, Ghazaleh RA, Blakemore WE, Ellard FM, Simmons DL, Newman JW, Stuart DI, King AM: Arginineglycine-aspartic acid-specific binding by foot-and-mouth disease viruses to the purified integrin αvβ3 in vitro. J Virol 1997; 71: 8357-8361. (Pubitemid 27446414)
43. Neff S, Baxt B: The ability of integrin αvβ3 to function as a receptor for foot-and-mouth disease virus is not dependent on the presence of complete subunit cytoplasmic domains. J Virol 2001; 75: 527-532.
44. Monaghan P, Gold S, Simpsom J, Zhang Z, Weinreb PH, Violette SM, Alexandersen S, Jackson T: The αvβ6 integrin receptor for foot-and-mouth disease virus is expressed constitutively on the epithelial cells targeted in cattle. J Gen Virol 2005; 86: 2769-2780. (Pubitemid 41410467)
45. Jackson T, Blakemore W, Newman JW, Knowles NJ, Mould AP, Humphries MJ, King AM: Foot-and-mouth disease virus is a ligand for the high-affinity binding conformation of integrin α5β1: influence of the leucine residue within the RGDL motif on selectivity of integrin binding. J Gen Virol 2000; 81: 1383-1391. (Pubitemid 30232725)
46. Baranowski E, Ruiz-Jarabo CM, Sevilla N, Andreu D, Beck E, Domingo E: Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in Aphthovirus receptor usage. J Virol 2000; 74: 1641-1647.
47. Duque H, Baxt B: Foot-and-mouth disease virus receptors: comparison of bovine alpha(V) integrin utilization by type A and O viruses. J Virol 2003; 77: 2500-2511.
48. Jackson T, Sheppard D, Denyer M, Blakemore W, King AM: The epithelial integrin αvβ6 is a receptor for foot-and-mouth disease virus. J Virol 2000b;74: 4949-4956. (Pubitemid 30313833)
49. O'Donnell V, LaRocco M, Duque H, Baxt B: Analysis of foot-and-mouth disease virus internalization events in cultured cells. J Virol 2005; 79: 8506-8518. (Pubitemid 40853551)
50. Rieder E, Henry T, Duque H, Baxt B: Analysis of a foot-and-mouth disease virus type A24 isolate containing an SGD receptor recognition site in vitro and its pathogenesis in cattle. J Virol 2005; 79: 12989-12998. (Pubitemid 41433218)
51. Breuss JM, Gillett N, Lu L, Sheppard D, Pytela R: Restricted distribution of integrin β 6 mRNA in primate epithelial tissues. J Histochem Cytochem 1993; 41: 1521-1527. (Pubitemid 23275254)
52. Duque H, LaRocco M, Golde Wt, Baxt B: Interactions of foot-and-mouth disease virus with soluble bovine αVβ3 and αVβ6 integrins. J Virol 2004; 78: 9773-9781.
53. Brown JK, McAleese SM, Thornton EM, Pate JA, Schock A, Macrae AI, Scott PR, Miller HRP, Collie DD: Integrin-avb6, a putative receptor for foot-and-mouth disease virus, is constitutively expressed in ruminant airways. J Histochem Cytochem 2006; 54: 807-816.
54. Dicara D, Burman A, Clark S, Berryman S, Howard MJ, Hart IR, Marshall JF, Jackson T: Foot-and-mouth disease virus forms a highly stable, EDTA-resistant complex with its principal receptor, integrin alphavbeta6: implications for infectiousness. J Virol 2008; 82: 1537-1546.
55. Ferris NP, Abrescia NG, Stuart DI, Jackson T, Burmana A, King DP, Paton DJ: Utility of recombinant integrin αvβ6 as a capture reagent in immunoassays for the diagnosis of foot-and-mouth disease. J Virol Method 2005; 127: 69-79.
56. Jackson T, Mould AP, Sheppard D, King AM: Integrin αvβ1 is a receptor for foot-and-mouth disease virus. J Virol 2002; 76: 935-941. (Pubitemid 34066398)
57. Jackson T, Clark S, Berryman S, Burman A, Cambier S, Mu D, Nishimura S, King A: Integrin αvβ8 functions as a receptor for foot-and-mouth disease virus: role of the β-chain cytodomain in integrin-mediated infection. J Virol 2004; 78: 4533-4540. (Pubitemid 38501073)
58. Cambier S, Mu D, O'Connell D, Boylen K, Travis W, Liu W, Broaddus VC, Nishimura SL: A role for the integrin αvβ8 in the negative regulation of epithelial cell growth. Can Res 2000; 60: 7084-7093. (Pubitemid 32059188)
59. Fjellbirkeland L, Cambier S, Broaddus VC, Hill A, Brunetta P, Dolganov G, Jablons D, Nishimura SL: Integrin αvβ8-mediated activation of transforming growth factor α inhibits human airway epithelial proliferation in intact bronchial tissue. Am J Pathol 2003; 163: 533-542. (Pubitemid 36909415)
60. Kjellen L, Lindah U: Proteoglycans: structures and interactions. Annu Rev Biochem 1991; 60: 443-475.
61. Jackson T, Ellard FM, Ghazaleh RA, Brookes SM, Blakemore WE, Corteyn AH, Stuart DI, Newman JW, King AM: Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J Virol 1996; 70: 5282-5287. (Pubitemid 26240701)
62. Haywood AM: Virus receptors: binding, adhesion strengthening, and changes in viral structure. J Virol 1994; 68: 1-5. (Pubitemid 24974601)
63. Fry EE, Lea SM, Jackson T, Newman JW, Ellard FM, Blakemore WE, Ghazaleh RA, Samuel A, King AM, Stuart DI: The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex. EMBO J 1999; 18: 543-554. (Pubitemid 29057239)
64. Sa-Carvalho D, Rieder E, Baxt B, Rodarte R, Tanuri A, Mason PW: Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J Virol 1997; 71: 5115-5123. (Pubitemid 27258183)
65. Baranowsky E, Sevilla N, Verdaguer N, Ruiz-Jarabo CM, Beck E, Domingo E: Multiple virulence determinants of foot-and-mouth diseases virus in cell culture. J Virol 1998; 72: 6362-6372. (Pubitemid 28323947)
66. O'Donnell V, Larocco M, Baxt B: Heparan sulfate-binding foot-and-mouth disease virus enters cells via caveola-mediated endocytosis. J Virol 2008; 82: 9075-9085.
67. Fry EE, Newman JW, Curry S, Najjam S, Jackson T, Blakemore W, Lea SM, Miller L, Burman A, King AM, Stuart DI: The structure of foot-and-mouth disease virus serotype A1061 alone and complexed with oligosaccharide receptor: receptor conservation in the face of antigenic variation. J Gen Virol 2005; 86: 1909-1920. (Pubitemid 40916374)
68. Zhao Q, Pacheco JM, Mason PW: Evaluation of genetically engineered derivatives of a Chinese strain of foot-and-mouth disease virus reveals a novel cell-binding site which functions in cell culture and in animals. J Virol 2003; 77: 3269-3280. (Pubitemid 36228110)
69. Gadek TR, McDowell RS: Discovery of small molecule leads in a biotechnology datastream. Drug Discov Today 2003; 8: 545-550. (Pubitemid 36775351)
70. Shimaoka M, Springer TA: Therapeutic antagonists and conformational regulation of integrin function. Nat Rev Drug Discov 2003; 2: 703-716. (Pubitemid 37361786)